08/11/2023
READY TO BURN FAT!!! CALL TODAY!!!
Keep in mind The US Food and Drug Administration (FDA) has approved Tirzepatide for chronic weight management in adults with obesity or overweight. We can assist you with creating a detailed plan for your weight loss journey. A once-weekly injection, Tirzepatide reduces appetite by activating two gut hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The dosage is increased over 4 to 20 weeks to achieve a weekly dose target of 5 mg, 10 mg, or 15 mg maximum.
www.oltcwellness.com
OLTC Wellness LLC